Every Form 4 that AdaptHealth Corp. (AHCO) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow AHCO and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AHCO filings page.
AdaptHealth Corp. (symbol: AHCO) is the issuer of record for a Form 4 filing submitted to the SEC. CURRIE HARRISS T reported acquisition or exercise transactions in this Form 4 filing.
AdaptHealth Corp. (AHCO) reported that its Chief Financial Officer, Harriss T. Currie, received a grant of 141,372 shares of Common Stock in the form of restricted stock units on September 9, 2026. These restricted stock units will be settled in common stock upon vesting, and Currie now directly holds 141,372 shares. No Rule 10b5-1 trading plan is reported for this transaction.
AdaptHealth Corp. director Dale B. Wolf reported an amended Form 4 reflecting the correct pricing for a recent share purchase. On 2026-08-06, he purchased 20,000 shares of common stock in open-market or private transactions at an average price of $6.30 per share, with individual trade prices ranging from $6.26 to $6.335. Following these transactions, he directly holds 143,234 shares of AdaptHealth common stock and indirectly holds 34,000 shares through the Dale B. Wolf Generation Skipping Trust, for which he serves as investment manager.
AdaptHealth Corp. director Kenneth A. Samet purchased additional common stock in an open-market or private transaction. On 2026-08-06 he bought 23,500 shares at $6.38 per share, bringing his directly held position to 48,569 shares of AdaptHealth common stock.
AdaptHealth Corp. director Dale B. Wolf reported open-market purchases of common stock on two consecutive days. On August 6, 2026, he purchased 20,000 shares at $6.37 per share, bringing his directly held position to 143,234 shares. On August 7, 2026, an additional 20,000 shares were purchased at a weighted average price of $5.86 per share, in multiple trades between $5.83 and $5.885, for the Dale B. Wolf Generation Skipping Trust, which now holds 34,000 shares with Wolf as investment manager.
AdaptHealth Corp. Chief Commercial Officer Russell E. Schuster III reported an open-market sale of 11,275 shares of Common Stock on July 1, 2026 at $10.44 per share. The filing shows he now directly holds 125,263 shares after the transaction.
The sale occurred automatically under a Rule 10b5-1 trading plan that Schuster adopted on March 2, 2026, indicating the trade was pre-scheduled rather than a discretionary market-timing decision.
AdaptHealth Corp. director David Solomon Williams III received a grant of 18,999 shares of common stock on June 24, 2026, recorded as restricted stock units that will settle in common shares upon vesting. The grant carried a price of $0.00 per share, reflecting equity-based compensation rather than a market purchase. Following this award, Williams has 64,044 shares of AdaptHealth common stock reported as directly owned, indicating this filing reflects a compensation-related acquisition, not an open-market transaction.
Weaver Susan T reported acquisition or exercise transactions in this Form 4 filing.
AdaptHealth Corp. director Susan T. Weaver reported a stock-based compensation award rather than an open-market trade. She received 18,999 shares of Common Stock in the form of restricted stock units at $0.00 per share, bringing her direct holdings to 40,345 shares. A separate line shows 73,472 shares of Common Stock held indirectly through the Susan T. Weaver 2025 Irrevocable Trust, for which her spouse and son are co-trustees and her spouse and children are beneficiaries. The restricted stock units will be settled in common stock upon vesting.
AdaptHealth Corp. director Terence J. Connors received an equity grant in the form of restricted stock units. On June 24, 2026, he was awarded 18,999 shares of Common Stock at no cash cost as a grant or award acquisition. These restricted stock units will be settled in common stock when they vest. Following this transaction, Connors directly holds 95,262 shares of AdaptHealth Common Stock, reflecting his updated equity position with the company.
BELINFANTI GREGORY reported acquisition or exercise transactions in this Form 4 filing.
AdaptHealth Corp. director Gregory Belinfanti received an equity grant in the form of restricted stock units. He was awarded 18,999 shares of common stock at no purchase price, increasing his direct holdings to 104,269 shares following the grant. The units will settle in common stock upon vesting.
Coppens Bradley J reported acquisition or exercise transactions in this Form 4 filing.
AdaptHealth Corp. director Bradley J. Coppens reported receiving a grant of 18,999 shares of Common Stock in the form of restricted stock units, which will be settled in common stock upon vesting. Following this award, he directly holds a total of 96,345 shares.
Lundberg Theodore B. reported acquisition or exercise transactions in this Form 4 filing.
AdaptHealth Corp. director Theodore B. Lundberg received a grant of 18,999 restricted stock units of common stock on June 24, 2026. These units will be settled in common stock upon vesting. After this award, he directly holds a reported total of 892,495 shares.
AdaptHealth Corp. director Dale B. Wolf reported a compensation-related equity award and updated holdings. He received 18,999 shares of common stock as a grant or award, at a stated price of $0.00 per share, structured as restricted stock units that will settle in common stock upon vesting. After this grant, he directly holds 123,234 shares. Separately, 14,000 shares are held indirectly by the Dale B. Wolf Generation Skipping Trust, for which he is the investment manager. No option exercises, open-market buys, or sales are shown in this filing, making the activity primarily a routine equity compensation update and ownership report.
SAMET KENNETH A reported acquisition or exercise transactions in this Form 4 filing.
AdaptHealth Corp. director Kenneth A. Samet reported two stock awards of common shares. On June 24, he received 6,070 shares at a reference price of $9.89 per share, bringing that holding line to 25,069 shares. He also received 18,999 restricted stock units at no cost, which will be settled in common stock upon vesting, with 18,999 shares shown as held after that award. These are compensation-related grants, not market purchases or sales.
AdaptHealth Corp. Chief Commercial Officer Russell E. Schuster III sold 11,275 shares of Common Stock on June 1, 2026 at $10.06 per share in an open-market transaction. The sale occurred automatically under a Rule 10b5-1 trading plan adopted on March 2, 2026.
After this transaction, he directly holds 136,538 shares of AdaptHealth Common Stock, indicating that the sale represents only a portion of his overall stake.
AdaptHealth Corp. reported that Chief Operating Officer Daniel Edward McFadden received an equity award in the form of restricted stock units. On the transaction date, he acquired 20,134 shares of Common Stock at no cash cost as a grant, increasing his direct holdings to 103,376 shares after the award. The footnote explains that these shares are restricted stock units that will be settled in common stock when they vest, meaning he does not receive all shares immediately but over time as vesting conditions are met.
AdaptHealth Corp. Chief Technology Officer Albert A. Prast filed an amended Form 4 to correct his reported share ownership. The amendment re-reports a prior tax-withholding disposition of 58,203 shares of common stock at $10.33 per share used to cover tax obligations, not an open-market sale. After reflecting this correction and prior filings that overstated his holdings by 135,443 shares, Prast is shown as beneficially owning 338,712 shares of common stock directly.
AdaptHealth Corp. insiders reported open-market purchases of common stock by entities affiliated with One Equity Partners. OEP AHCO Investment Holdings, LLC bought 447,100 shares on March 20, 2026 at a weighted average price of $9.9121 per share and 727 shares on March 19, 2026 at a weighted average price of $9.9417 per share.
After these trades, the filing shows 16,312,698 shares of AdaptHealth common stock held indirectly following the latest transaction. The securities are held directly by OEP AHCO Investment Holdings, LLC, which is owned by several parallel One Equity Partners funds. A six-member investment committee of OEP VII GP, including Richard Cashin, may be deemed to have voting and investment discretion, though each reporting person disclaims beneficial ownership beyond its or his pecuniary interest.
AdaptHealth Corp. large shareholder entities affiliated with One Equity Partners reported open-market purchases of a total of 2,046,691 shares of common stock over three days in March. The shares were bought indirectly through OEP AHCO Investment Holdings, LLC at weighted average prices around $9.73 per share.
Purchases included 820,528 shares on March 10 at a weighted average price of $9.7287, 536,827 shares on March 11 at $9.7281, and 689,336 shares on March 12 at $9.7299. After these transactions, the affiliated entities reported indirect holdings of 15,864,871 AdaptHealth shares, with footnotes noting weighted-average pricing ranges and customary beneficial ownership disclaimers.
AdaptHealth Corp. saw a significant insider-related purchase as an entity associated with major holder Richard M. Cashin Jr. bought a total of 447,827 shares of common stock in open-market transactions on March 19 and 20, 2026. The shares were acquired indirectly through OEP AHCO Investment Holdings, LLC and related One Equity Partners funds, rather than by Cashin personally. After these purchases, the reporting group held 16,312,698 shares indirectly. The prices were reported as weighted averages, with trades executed in ranges between $9.81 and $9.95 per share.
AdaptHealth Corp. Chief Technology Officer Albert A. Prast exercised employee stock options to acquire 89,451 shares of common stock at $4.38 per share. To cover associated obligations, 58,203 shares of common stock were surrendered at $10.33 per share as a tax-withholding disposition. After these compensation-related transactions, Prast directly owns 474,155 shares of AdaptHealth common stock, reflecting a routine option exercise with part of the shares withheld rather than sold in the open market.
AdaptHealth Corp. reported that entities associated with major shareholder Richard M. Cashin Jr. made open-market purchases of 2,046,691 shares of common stock over three days. The shares were bought indirectly through OEP AHCO Investment Holdings, VI LLC at prices between $9.55 and $9.95 per share.
Following these transactions, the reporting group holds 15,864,871 shares of AdaptHealth common stock indirectly. Footnotes state that One Equity Partners funds own the investment vehicle, that an OEP VII GP investment committee including Cashin may be deemed to have voting and investment discretion, and that each reporting person disclaims beneficial ownership beyond their pecuniary interest.
AdaptHealth Corp. director Susan T. Weaver reported a bona fide gift of 73,472 shares of AdaptHealth common stock, transferred to the Susan T. Weaver 2025 Irrevocable Trust for the benefit of her spouse and children. The filing lists the transaction as a gift transfer with no sale price.
After these transactions, Weaver directly holds 21,346 shares of AdaptHealth common stock and indirectly holds 73,472 shares through the irrevocable trust, reflecting a shift of ownership to a family estate-planning vehicle rather than a market sale.
AdaptHealth Corp. director Dale B. Wolf reported an open-market purchase of common stock. On February 27, 2026, he bought 8,000 shares of AdaptHealth common stock at a weighted average price of $8.96 per share.
After this transaction, Wolf directly owned 104,235 common shares. The filing also reports an additional 14,000 common shares held indirectly by a trust, reflecting indirect ownership separate from his direct holdings.
AdaptHealth Corp. insider Richard W. Rew II, the company’s CLO and General Counsel, reported an open-market purchase of 5,000 shares of common stock at $8.91 per share. Following this Form 4 transaction, his directly owned AdaptHealth shareholdings increased to 107,097 shares.
AdaptHealth Corp.'s Chief Legal Officer and General Counsel, Richard W. Rew II, reported an equity award of 53,688 shares of common stock on January 30, 2026, coded as an acquisition. The filing shows these shares as restricted stock units that will be settled in common stock when they vest.
After this grant, Rew beneficially owned a total of 102,097 shares of AdaptHealth common stock in direct ownership, reflecting his updated equity stake as a senior officer.
AdaptHealth Corp.’s Chief Commercial Officer Russell E. Schuster III reported an equity award of 48,807 shares of common stock on 01/30/2026. The Form 4 shows the transaction coded as an acquisition at a reported price of $0.00 per share, indicating a stock-based grant.
A footnote explains these 48,807 shares are restricted stock units that will be settled in common stock upon vesting. After this award, Schuster beneficially owns 147,813 shares of AdaptHealth common stock in direct form.
AdaptHealth Corp.'s Chief Operating Officer, Toby Scott Barnhart, received a grant of restricted stock units (RSUs). On 01/30/2026, he was awarded 68,330 shares of common stock at a price of $0 per share, classified as an acquisition.
These RSUs will be settled in AdaptHealth common stock upon vesting, meaning the shares are delivered over time as conditions are met. Following this grant, Barnhart beneficially owns 220,654 shares of AdaptHealth common stock in direct ownership.
AdaptHealth Corp.'s Chief Technology Officer, Albert A. Prast, reported an equity award in the form of restricted stock units. On January 30, 2026, he acquired 63,449 shares of common stock at $0 per share, representing restricted stock units that will settle in common stock upon vesting. Following this grant, he beneficially owned 442,907 shares of AdaptHealth common stock in direct ownership.
AdaptHealth Corp. reported that Chief Business Systems Officer Daniel McFadden received an award of 29,284 shares of common stock on 01/30/2026. The shares are in the form of restricted stock units that will convert into common stock when they vest.
Following this grant, McFadden beneficially owns 83,242 shares of AdaptHealth common stock in direct ownership. The award was reported at a price of $0 per share, consistent with a typical equity compensation grant rather than an open-market purchase.
AdaptHealth Corp. Chief Executive Officer and director Suzanne Foster reported an award of 329,449 shares of common stock on January 30, 2026. The filing explains these shares are restricted stock units that will be settled in common stock when they vest, effectively tying compensation to future service or performance.
After this grant, Foster directly beneficially owns 924,050 shares of AdaptHealth common stock. The transaction price is shown as $0 per share, consistent with a stock-based compensation grant rather than an open-market purchase.
AdaptHealth Corp.'s Chief Accounting Officer, Christine E. Archbold, reported an equity award in the form of restricted stock units. On January 30, 2026, she acquired 32,213 shares of common stock, represented by restricted stock units that will be settled in common stock upon vesting at a price of $0 per share. Following this grant, she beneficially owns 107,198 shares of AdaptHealth common stock, held directly.
AdaptHealth Corp.'s Chief Financial Officer, Jason A. Clemens, reported an equity award of company stock. On January 30, 2026, he acquired 126,899 shares of Common Stock at a price of $0 per share, bringing his directly held beneficial ownership to 673,481 shares.
The newly reported shares represent restricted stock units that will be settled in common stock when they vest, providing the CFO with additional long-term, stock-based compensation tied to the company’s performance and continued service.
AdaptHealth Corp. director Theodore B. Lundberg reported acquiring 13,740 shares of AdaptHealth common stock on January 9, 2026. The filing shows the shares were received at a price of $0 per share and are described as restricted stock units that will be settled in common stock upon vesting. Following this transaction, Lundberg is shown as beneficially owning 873,496 shares of AdaptHealth common stock with direct ownership.
AdaptHealth Corp. director Gregory Belinfanti reported an equity award in the form of restricted stock units. On January 9, 2026, he was granted 11,776 shares of AdaptHealth common stock at a reported price of $0 per share, reflecting a compensatory award rather than an open‑market purchase. These shares are structured as restricted stock units that will be settled in common stock when they vest. Following this grant, Belinfanti directly beneficially owned 85,270 shares of AdaptHealth common stock.
AdaptHealth Corp. director David S. Williams III reported an open-market sale of 5,000 shares of the company’s common stock on December 4, 2025 at a price of $9.43 per share. After this transaction, he beneficially owns 45,045 shares of AdaptHealth common stock, held directly.